Tirzepatide: Tirzepatide, in the SURPASS clinical trials, has demonstrated impressive results in glycemic control
Cell Reports , 44 (4), 115529 Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B
Discuss with your healthcare provider whether transitioning to a different GLP-1 receptor agonist is appropriate, as cross-reactivity is not guaranteed and many users who react to one medication tolerate another without difficulty
Most anxiety patients experience is secondarycaused by nausea, rapid metabolic shifts, or the psychological adjustment to rapid weight loss
The results of these few studies are conflicting, with some reporting zero impact on testosterone and some demonstrating that it can improve sexual function